Skip to main content
. 2004 Mar;78(6):2722–2728. doi: 10.1128/JVI.78.6.2722-2728.2004

TABLE 1.

Characteristics of X4 HIV-1 variants

Patient Serologic statuse Early virus variants
Late virus variants
n Time to seroconversion or entry (mo)a Time to X4 (mo)a Coreceptor usageb CD4 T-cell count (cells/μl) RNA load (log no. of copies/ml) n Time to seroconversion or entry (mo) Time to X4 (mo) Coreceptor usageb CD4 T-cell count (cells/μl) RNA load (log no. of copies/ml)
ACH208 Sc 3 18.5 4.5 R5X4 (2) 440 4.4 5 64.1 50.1 X4 (5) 30 NAf
X4 (1)
ACH039 Sc 6 18.0 1.9 R3R5X4 (3) 570 4.7 5 48.5 32.4 R3X4 (5) 10 NA
X4d (3)
ACH0171 Sc 4 66.8 5.2 R3R5X4 (3) 380 4.9 4 89.3 27.0 R3R5X4 (1) 130 5.4
X4 (1) X4 (3)
ACH1120 Sc 5 53.1 7.3 X4d 270 6.4 4 66.2 20.4 X4d 10 NA
ACH6052 Sp 5 0c c X4d 500 NA 5 32.0 c X4d 20 NA
a

When virus variants from multiple time points were analyzed, the average time to seroconversion or first detection of X4 HIV-1 variants is given.

b

The absolute number of virus variants with the indicated coreceptor preference in transfected U87 cells is given in parentheses. Data are available from a previous study (45).

c

Patient ACH6052 was seropositive and carried X4 variants at the time of entry into the cohort. No estimated time of first detection of X4 HIV-1 variants can therefore be given.

d

CXCR4 usage for entry as determined in MT2 cell line and replication in CCR5Δ/Δ PBMC. Other coreceptor preferences in transfected U87 cells were not tested.

e

Sc, seroconverter; Sp, seroprevalent.

f

NA, not available.